GRNET, EuroCC@Greece coordinator, in collaboration with the innovative Greek SME Bioemtech, has taken an important step toward leveraging HPC to address a critical clinical challenge — achieving personalised pediatric dosimetry in nuclear medicine.

In an interview for FFplus (Fortissimo Plus), Tina Črnigoj Marc (Arctur) speaks with Panagiotis Papadimitroulas, Associate Professor of Biomedical Informatics at the University of Thessaly and co-founder and software advisor at Bioemtech. Bioemtech is a Greek specialised organisation that provides services to assist pharmaceutical and biotechnology companies.

Dr. Papadimitroulas explains how Bioemtech is accelerating preclinical research, towards clinical translation for promising drugs, through our high-quality services and products. He also shares insights from their successful participation in the FF4EuroHPC Business Experiment and the newest FFplus Innovation Study.

Watch the video interview here.

Read the full interview here.

Find out more about the PediDose Success Story here.